Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Stack

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Hospital Medicine (London, England : 1998)|April 10, 1999
Novel treatments in inflammatory bowel diseaseS Pathmakanthan, W A Stack
Expert Opinion on Investigational Drugs|July 5, 2005
Novel approaches to inflammatory bowel diseaseB C McKaig, W A Stack
European Journal of Gastroenterology & Hepatology|February 12, 1998
Specific mediator-directed therapy for gastrointestinal diseasesW A Stack, C J Hawkey
Expert Opinion on Pharmacotherapy|March 16, 2001
Current pharmacotherapy for inflammatory bowel diseaseB C McKaig, W A Stack
Gut|July 1, 1996
Nitric oxide donating compounds stimulate human colonic ion transport in vitroW A Stack, B Filipowicz, C J Hawkey
Drugs|October 20, 1998
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disordersP Richardson, C J Hawkey, W A Stack
The American Journal of Physiology|April 13, 1999
TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cellsJ Beltinger, C J Hawkey, W A Stack
Alimentary Pharmacology & Therapeutics|November 3, 1998
Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitisW A Stack, R G Long, C J Hawkey
Alimentary Pharmacology & Therapeutics|May 8, 1999
Immunosuppressive therapy for ulcerative colitis: results of a nation-wide survey among consultant physician members of the British Society of GastroenterologyW A Stack, D Williams, M Stevenson, et al.
Gastroenterology|December 3, 1998
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative ColitisW A Stack, D Jenkins, P Vivet, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Hospital Medicine (London, England : 1998)|April 10, 1999
Novel treatments in inflammatory bowel diseaseS Pathmakanthan, W A Stack
Expert Opinion on Investigational Drugs|July 5, 2005
Novel approaches to inflammatory bowel diseaseB C McKaig, W A Stack
European Journal of Gastroenterology & Hepatology|February 12, 1998
Specific mediator-directed therapy for gastrointestinal diseasesW A Stack, C J Hawkey
Expert Opinion on Pharmacotherapy|March 16, 2001
Current pharmacotherapy for inflammatory bowel diseaseB C McKaig, W A Stack
Gut|July 1, 1996
Nitric oxide donating compounds stimulate human colonic ion transport in vitroW A Stack, B Filipowicz, C J Hawkey
Drugs|October 20, 1998
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disordersP Richardson, C J Hawkey, W A Stack
The American Journal of Physiology|April 13, 1999
TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cellsJ Beltinger, C J Hawkey, W A Stack
Alimentary Pharmacology & Therapeutics|November 3, 1998
Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitisW A Stack, R G Long, C J Hawkey
Alimentary Pharmacology & Therapeutics|May 8, 1999
Immunosuppressive therapy for ulcerative colitis: results of a nation-wide survey among consultant physician members of the British Society of GastroenterologyW A Stack, D Williams, M Stevenson, et al.
Gastroenterology|December 3, 1998
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative ColitisW A Stack, D Jenkins, P Vivet, et al.
Pageof 2